A Decade of Pursuing Light, A Future Full of Hope: Tracing the Milestones and Defining Moments of CSCO BC

A Decade of Pursuing Light, A Future Full of Hope: Tracing the Milestones and Defining Moments of CSCO BC

In April 2016, a pink seed took root in Beijing with the launch of preparations for the Breast Cancer Committee of the Chinese Society of Clinical Oncology (CSCO BC). Driven by vision, dedication, and perseverance, a group of Chinese physicians came together to support and empower patients with breast cancer through science, compassion, and unwavering commitment to care.
Sino-French Breast Reconstruction Congress | Professor Shengchun Liu: Pursuing Maximum Benefit with Minimal Invasiveness — Individualized Breast Reconstruction Practice and Insights for Chinese Women

Sino-French Breast Reconstruction Congress | Professor Shengchun Liu: Pursuing Maximum Benefit with Minimal Invasiveness — Individualized Breast Reconstruction Practice and Insights for Chinese Women

The 15th Sino-French Breast Reconstruction Congress and the 13th Sino-French Breast Cancer Academic Conference recently concluded successfully in Chongqing, China. During the meeting, Professor Shengchun Liu from the First Affiliated Hospital of Chongqing Medical University sat down with Oncology Frontier to share the “CQMU experience” accumulated over more than two decades. In the interview, Professor Liu discussed the evolution of breast reconstruction strategies from an early predominance of autologous flap reconstruction to the current implant-oriented approach, and explained how breast surgeons should continue to uphold the principle of “achieving optimal outcomes with the least possible surgical trauma” amid the growing trends of minimally invasive surgery and artificial intelligence.
The World Needs Me, and I Need the World — Professor Kefeng Ding: Chinese and International Experts Discuss Key Colorectal Surgical Techniques as ICSTAC Builds New Pathways for Global Surgical Training

The World Needs Me, and I Need the World — Professor Kefeng Ding: Chinese and International Experts Discuss Key Colorectal Surgical Techniques as ICSTAC Builds New Pathways for Global Surgical Training

On April 24, 2026, the China–Spain–Canada Colorectal Surgery Clinical Practice Symposium was successfully held at the Chengdong Campus of the Second Affiliated Hospital, Zhejiang University School of Medicine. Renowned surgical experts and scholars from China, Spain, and Canada gathered to engage in in-depth academic exchanges focused on live surgical demonstrations, operative technique sharing, and presentations of cutting-edge technologies.
CURC & ARUF | Professor Linhui Wang: Addressing Complications in Retroperitoneal Surgery and Looking Ahead to the Future of Domestic Surgical Robots

CURC & ARUF | Professor Linhui Wang: Addressing Complications in Retroperitoneal Surgery and Looking Ahead to the Future of Domestic Surgical Robots

At this year’s CURC & ARUF Congress, Professor Linhui Wang from the First Affiliated Hospital of the Naval Medical University (Shanghai Changhai Hospital) served as Executive Chair of the meeting. During the Master Lecture session, he delivered a systematic analysis of the causes underlying postoperative abdominal wall bulging following retroperitoneal laparoscopic surgery. The congress also featured extensive live surgical demonstrations and dedicated sessions focused on the clinical application of domestically developed surgical robotic systems. In light of these key topics, Oncology Frontier invited Professor Wang for an in-depth interview.
CUDA Yanqi Lake Conference | Exclusive Interview with Professor Hong Liao: In the Era of Precision Therapy for Prostate Cancer, How Do We Move from “Experience-Driven” to “Evidence-Driven” Care?

CUDA Yanqi Lake Conference | Exclusive Interview with Professor Hong Liao: In the Era of Precision Therapy for Prostate Cancer, How Do We Move from “Experience-Driven” to “Evidence-Driven” Care?

Prostate cancer is the second most commonly diagnosed malignancy and the fifth leading cause of cancer-related death among men worldwide. In recent years, with the rapid advancement of molecular biology technologies and the emergence of novel therapeutic agents, prostate cancer management has officially entered the era of precision medicine. Clinical decision-making is undergoing a profound transformation—from the traditional “one-size-fits-all” approach to individualized treatment strategies guided by precise staging and molecular profiling.
CUDA Yanqi Lake Conference | From Personal Mastery to Broader Impact: The Growth and Legacy of a Urologic Surgeon

CUDA Yanqi Lake Conference | From Personal Mastery to Broader Impact: The Growth and Legacy of a Urologic Surgeon

The 2026 Yanqi Lake Academic Conference for Urologists was successfully held in Beijing. During the meeting, Conference Chair Professor Nianzeng Xing, Vice President of the National Cancer Center / Cancer Hospital, Chinese Academy of Medical Sciences, shared his personal journey during the special session “From a Skilled Commander to a Strategic Leader.” He reflected on his transformation from a surgeon striving for technical perfection in the operating room to a discipline leader committed to cultivating teams and advancing the field as a whole.
AOT 2026 | Professor Matthias Stelljes: Therapeutic Pathways and Key Decision-Making Considerations in Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia

AOT 2026 | Professor Matthias Stelljes: Therapeutic Pathways and Key Decision-Making Considerations in Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia

To comprehensively improve public health and strengthen strategies for the prevention and treatment of major diseases, medical innovation and international collaboration have become key drivers of clinical progress. Against this backdrop, the 2026 Beijing International Hematopoietic Stem Cell Transplantation Conference (AOT) was successfully held in Beijing from April 24 to 25, 2026. Organized by the Hematology Branch of the China International Exchange and Promotive Association for Medical and Health Care and hosted by the National Clinical Research Center for Hematologic Diseases and the Peking University Institute of Hematology, this year’s conference centered on the theme “The Art of Transplantation.” The meeting brought together leading hematology experts from around the world to discuss cutting-edge innovations and future directions in hematopoietic stem cell transplantation.
AOT 2026 | Professor Donal P. McLornan: Challenges, Strategies, and Future Directions for Hematopoietic Stem Cell Transplantation in MDS/MPN

AOT 2026 | Professor Donal P. McLornan: Challenges, Strategies, and Future Directions for Hematopoietic Stem Cell Transplantation in MDS/MPN

To comprehensively improve public health and strengthen strategies for the prevention and treatment of major diseases, medical innovation and international collaboration have become key drivers of clinical progress. Against this backdrop, the 2026 Beijing International Hematopoietic Stem Cell Transplantation Conference (AOT) was successfully held in Beijing from April 24 to 25, 2026. Organized by the Hematology Branch of the China International Exchange and Promotive Association for Medical and Health Care and hosted by the National Clinical Research Center for Hematologic Diseases and the Peking University Institute of Hematology, this year’s conference centered on the theme “The Art of Transplantation.” The meeting brought together leading hematology experts from around the world to discuss cutting-edge innovations and emerging trends in hematopoietic stem cell transplantation.